Inhibrx Biosciences, Inc.
|
Dec-25 |
Dec-24 |
Dec-23 |
Dec-22 |
Dec-21 |
Dec-20 |
Dec-19 |
Dec-18 |
Dec-17 |
Dec-16 |
| Total revenue |
0.00 |
0.00 |
0.00 |
0.00 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
| Cost of revenue |
0.00 |
0.00 |
0.00 |
0.11 |
0.00 |
0.07 |
0.05 |
0.03 |
0.03 |
0.02 |
| Gross profit |
0.00 |
0.00 |
0.00 |
-0.11 |
0.00 |
-0.06 |
-0.04 |
-0.03 |
-0.02 |
-0.01 |
| Selling, general and administrative |
0.02 |
0.13 |
0.03 |
0.02 |
0.01 |
0.01 |
0.01 |
0.00 |
0.00 |
0.00 |
| Research and development |
0.11 |
0.20 |
0.19 |
0.11 |
0.07 |
0.07 |
0.05 |
0.03 |
0.03 |
0.02 |
| Other operating expenses |
0.00 |
0.00 |
0.00 |
-0.11 |
-0.07 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Operating income |
-0.14 |
-0.33 |
-0.22 |
-0.13 |
-0.08 |
-0.07 |
-0.04 |
-0.03 |
-0.02 |
-0.01 |
| Non-operating income (net) |
-0.01 |
2.02 |
-0.02 |
-0.02 |
-0.01 |
-0.01 |
-0.01 |
0.00 |
0.00 |
0.00 |
| Income before tax |
-0.14 |
1.69 |
-0.24 |
-0.15 |
-0.08 |
-0.08 |
-0.05 |
-0.03 |
-0.02 |
-0.01 |
| Income tax expense |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Net income |
-0.14 |
1.69 |
-0.24 |
-0.15 |
-0.08 |
-0.08 |
-0.05 |
-0.03 |
-0.02 |
-0.01 |
Show Quarterly Income Statement
|
Mar-26 |
Dec-25 |
Sep-25 |
Jun-25 |
Mar-25 |
Dec-24 |
Sep-24 |
Jun-24 |
Mar-24 |
Dec-23 |
Sep-23 |
Jun-23 |
Mar-23 |
Dec-22 |
Sep-22 |
Jun-22 |
Mar-22 |
Dec-21 |
Sep-21 |
Jun-21 |
Mar-21 |
Dec-20 |
Sep-20 |
Jun-20 |
Mar-20 |
Dec-19 |
Sep-19 |
Jun-19 |
Mar-19 |
Dec-18 |
Jun-18 |
Mar-18 |
Dec-17 |
| Total revenue |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
| Cost of revenue |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.03 |
|
|
|
|
0.02 |
|
0.02 |
0.02 |
|
0.00 |
0.01 |
0.01 |
0.01 |
0.00 |
0.01 |
0.01 |
0.01 |
| Gross profit |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-0.03 |
0.00 |
0.00 |
0.00 |
0.00 |
-0.02 |
0.00 |
-0.01 |
-0.02 |
0.00 |
0.00 |
-0.01 |
-0.01 |
0.00 |
0.00 |
-0.01 |
-0.01 |
-0.01 |
| Selling, general and administrative |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.02 |
0.01 |
0.09 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Research and development |
0.02 |
0.03 |
0.03 |
0.02 |
0.04 |
0.03 |
0.04 |
0.07 |
0.06 |
0.08 |
0.04 |
0.03 |
0.04 |
0.03 |
0.02 |
0.03 |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
0.01 |
0.01 |
0.01 |
0.01 |
0.00 |
0.01 |
0.01 |
0.01 |
| Other operating expenses |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-0.01 |
| Operating income |
-0.03 |
-0.03 |
-0.03 |
-0.03 |
-0.04 |
-0.05 |
-0.05 |
-0.16 |
-0.07 |
-0.09 |
-0.05 |
-0.04 |
-0.04 |
-0.04 |
-0.03 |
-0.03 |
-0.03 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.01 |
-0.01 |
0.00 |
0.00 |
-0.01 |
-0.01 |
-0.01 |
| Non-operating income (net) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
2.02 |
0.00 |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
-0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Income before tax |
-0.03 |
-0.03 |
-0.04 |
-0.03 |
-0.04 |
-0.05 |
-0.04 |
1.86 |
-0.08 |
-0.09 |
-0.05 |
-0.05 |
-0.05 |
-0.04 |
-0.04 |
-0.04 |
-0.03 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.01 |
0.00 |
0.00 |
-0.01 |
-0.01 |
-0.01 |
| Income tax expense |
|
|
|
0.00 |
|
|
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
-0.01 |
| Net income |
-0.03 |
-0.03 |
-0.04 |
-0.03 |
-0.04 |
-0.05 |
-0.04 |
1.86 |
-0.08 |
-0.09 |
-0.05 |
-0.05 |
-0.05 |
-0.04 |
-0.04 |
-0.04 |
-0.03 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.02 |
-0.01 |
0.00 |
0.00 |
-0.01 |
-0.01 |
-0.01 |
|
Dec-25 |
Dec-24 |
Dec-23 |
Dec-22 |
Dec-21 |
Dec-20 |
Dec-19 |
Dec-18 |
Dec-17 |
Dec-16 |
| Cash and cash equivalents |
0.12 |
0.15 |
0.28 |
0.27 |
0.13 |
0.13 |
0.01 |
0.00 |
0.01 |
0.02 |
| Short-term investments |
|
|
|
|
|
|
|
|
|
|
| Accounts receivable, net |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Inventories |
|
|
|
0.00 |
0.00 |
-0.13 |
0.00 |
0.00 |
0.00 |
|
| Other current assets |
0.01 |
0.01 |
0.02 |
0.01 |
0.01 |
0.13 |
0.00 |
0.00 |
0.00 |
0.00 |
| Total current assets |
0.13 |
0.16 |
0.30 |
0.28 |
0.14 |
0.13 |
0.02 |
0.01 |
0.02 |
0.02 |
| Property, plant and equipment, net |
|
|
|
|
|
|
|
|
|
|
| Goodwill |
|
|
|
|
|
|
|
|
|
|
| Intangible assets |
|
|
|
|
|
|
|
|
|
|
| Long-term investments |
|
|
|
|
|
|
|
|
|
|
| Other non-current assets |
|
|
|
|
|
|
|
|
|
|
| Total assets |
0.15 |
0.18 |
0.31 |
0.29 |
0.15 |
0.14 |
0.03 |
0.01 |
0.02 |
0.02 |
|
| Accounts payable |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.00 |
0.01 |
0.00 |
0.00 |
| Short-term debt |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.01 |
0.01 |
0.00 |
| Current portion of long-term debt |
|
|
|
|
|
|
|
|
|
|
| Deferred revenue |
|
|
|
|
|
|
|
|
|
|
| Other current liabilities |
0.03 |
0.03 |
0.04 |
0.02 |
0.01 |
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
| Long-term debt |
0.10 |
|
0.21 |
|
|
|
|
|
|
|
| Capital lease obligations |
0.01 |
0.01 |
0.00 |
0.01 |
|
|
|
|
|
|
| Other non-current liabilities |
|
|
|
|
|
|
|
|
|
|
| Total liabilities |
0.14 |
0.05 |
0.26 |
0.23 |
0.10 |
0.07 |
0.12 |
0.07 |
0.04 |
0.02 |
|
| Common stock and paid-in capital |
0.25 |
0.24 |
0.66 |
0.43 |
0.28 |
0.22 |
-0.02 |
-0.04 |
0.00 |
0.00 |
| Retained earnings |
-0.25 |
-0.11 |
-0.61 |
-0.37 |
-0.23 |
-0.15 |
-0.07 |
-0.02 |
-0.03 |
-0.01 |
| Common shares outstanding |
15 |
14 |
47 |
40 |
38 |
25 |
37 |
27 |
29 |
37 |
Show Quarterly Balance Sheet
|
Mar-26 |
Dec-25 |
Sep-25 |
Jun-25 |
Mar-25 |
Dec-24 |
Sep-24 |
Jun-24 |
Mar-24 |
Dec-23 |
Sep-23 |
Jun-23 |
Mar-23 |
Dec-22 |
Sep-22 |
Jun-22 |
Mar-22 |
Dec-21 |
Sep-21 |
Jun-21 |
Mar-21 |
Dec-20 |
Sep-20 |
Jun-20 |
Mar-20 |
Dec-19 |
Sep-19 |
Jun-19 |
Mar-19 |
Dec-18 |
Jun-18 |
Mar-18 |
Dec-17 |
| Cash and cash equivalents |
0.16 |
0.12 |
0.15 |
0.19 |
0.22 |
0.15 |
0.20 |
0.23 |
0.25 |
0.28 |
0.34 |
0.19 |
0.23 |
0.27 |
0.15 |
0.18 |
0.14 |
0.13 |
0.11 |
0.13 |
0.11 |
0.13 |
0.13 |
0.01 |
0.00 |
0.01 |
|
0.03 |
0.01 |
0.00 |
|
-0.01 |
0.01 |
| Short-term investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.03 |
|
| Accounts receivable, net |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
0.00 |
|
0.00 |
0.00 |
0.00 |
|
|
0.00 |
| Inventories |
|
|
|
|
|
|
|
|
|
|
0.00 |
0.01 |
0.00 |
0.00 |
0.00 |
|
0.01 |
0.00 |
0.01 |
0.00 |
0.00 |
-0.13 |
0.00 |
0.00 |
|
0.00 |
|
0.00 |
0.00 |
0.00 |
|
|
0.00 |
| Other current assets |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.02 |
0.02 |
0.03 |
0.01 |
0.01 |
0.01 |
0.01 |
0.00 |
0.00 |
0.01 |
0.00 |
0.00 |
0.00 |
0.13 |
0.00 |
0.00 |
0.00 |
0.00 |
|
0.00 |
0.00 |
0.00 |
|
|
0.00 |
| Total current assets |
0.17 |
0.13 |
0.16 |
0.19 |
0.22 |
0.16 |
0.21 |
0.24 |
0.27 |
0.30 |
0.36 |
0.20 |
0.24 |
0.28 |
0.15 |
0.18 |
0.15 |
0.14 |
0.12 |
0.13 |
0.11 |
0.13 |
0.13 |
0.01 |
0.00 |
0.02 |
|
0.03 |
0.01 |
0.01 |
|
0.01 |
0.02 |
| Property, plant and equipment, net |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Goodwill |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Intangible assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Long-term investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other non-current assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total assets |
0.18 |
0.15 |
0.18 |
0.21 |
0.24 |
0.18 |
0.22 |
0.26 |
0.29 |
0.31 |
0.37 |
0.21 |
0.25 |
0.29 |
0.16 |
0.19 |
0.16 |
0.15 |
0.13 |
0.14 |
0.12 |
0.14 |
0.14 |
0.02 |
0.02 |
0.03 |
|
0.05 |
0.02 |
0.01 |
|
|
0.02 |
|
| Accounts payable |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.02 |
0.01 |
0.01 |
0.00 |
|
0.00 |
0.00 |
0.01 |
|
|
0.00 |
| Short-term debt |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
0.00 |
|
0.01 |
0.01 |
0.01 |
|
|
0.01 |
| Current portion of long-term debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Deferred revenue |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other current liabilities |
0.02 |
0.03 |
0.03 |
0.03 |
0.03 |
0.03 |
0.03 |
0.02 |
0.05 |
0.04 |
0.03 |
0.02 |
0.02 |
0.02 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.02 |
0.02 |
0.02 |
0.00 |
|
0.00 |
0.00 |
0.00 |
|
|
0.00 |
| Long-term debt |
0.17 |
0.10 |
0.10 |
0.10 |
0.10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Capital lease obligations |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.01 |
0.00 |
0.00 |
0.00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Other non-current liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total liabilities |
0.21 |
0.14 |
0.14 |
0.14 |
0.15 |
0.05 |
0.04 |
0.04 |
0.28 |
0.26 |
0.24 |
0.24 |
0.24 |
0.23 |
0.20 |
0.20 |
0.13 |
0.10 |
0.10 |
0.10 |
0.06 |
0.07 |
0.05 |
0.04 |
0.07 |
0.12 |
|
0.11 |
0.08 |
0.07 |
|
|
0.04 |
|
| Common stock and paid-in capital |
0.26 |
0.25 |
0.25 |
0.25 |
0.24 |
0.24 |
0.24 |
0.23 |
0.70 |
0.66 |
0.65 |
0.44 |
0.44 |
0.43 |
0.30 |
0.29 |
0.29 |
0.28 |
0.23 |
0.23 |
0.23 |
0.22 |
0.22 |
0.09 |
0.04 |
-0.02 |
0.00 |
-0.03 |
-0.04 |
-0.04 |
0.00 |
0.00 |
0.00 |
| Retained earnings |
-0.28 |
-0.25 |
-0.21 |
-0.18 |
-0.15 |
-0.11 |
-0.06 |
-0.01 |
-0.69 |
-0.61 |
-0.52 |
-0.47 |
-0.42 |
-0.37 |
-0.33 |
-0.30 |
-0.26 |
-0.23 |
-0.21 |
-0.19 |
-0.16 |
-0.15 |
-0.13 |
-0.11 |
-0.09 |
-0.07 |
|
-0.03 |
-0.02 |
-0.02 |
|
|
-0.03 |
| Common shares outstanding |
16 |
15 |
15 |
15 |
15 |
14 |
15 |
15 |
55 |
54 |
47 |
44 |
44 |
43 |
39 |
39 |
39 |
39 |
38 |
38 |
38 |
38 |
27 |
36 |
29 |
29 |
29 |
29 |
29 |
28 |
29 |
29 |
18 |
|
Dec-25 |
Dec-24 |
Dec-23 |
Dec-22 |
Dec-21 |
Dec-20 |
Dec-19 |
Dec-18 |
Dec-17 |
Dec-16 |
| Net income |
|
|
|
|
|
|
|
|
|
|
| Depreciation, depletion and amortization |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Stock-based compensation |
0.01 |
0.06 |
0.02 |
0.02 |
0.02 |
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
| Change in inventory |
|
|
|
|
-0.01 |
0.01 |
0.00 |
0.00 |
0.00 |
|
| Other working capital changes |
-0.14 |
-0.26 |
-0.22 |
-0.14 |
-0.09 |
-0.06 |
-0.03 |
-0.03 |
-0.02 |
-0.02 |
| Capital expenditures |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Others incl. marketable securities changes |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Dividend payout |
|
|
|
|
|
|
|
0.00 |
0.00 |
|
| Common stock repurchases |
|
|
|
|
|
|
|
|
|
|
| Net Debt Issuance |
0.10 |
0.07 |
0.20 |
0.26 |
0.08 |
0.17 |
0.04 |
0.01 |
0.01 |
0.03 |
|
| Change in cash |
-0.03 |
-0.13 |
0.00 |
0.14 |
0.00 |
0.12 |
0.01 |
-0.01 |
-0.01 |
0.01 |
Show Quarterly Cash Flow
|
Mar-26 |
Dec-25 |
Sep-25 |
Jun-25 |
Mar-25 |
Dec-24 |
Sep-24 |
Jun-24 |
Mar-24 |
Dec-23 |
Sep-23 |
Jun-23 |
Mar-23 |
Dec-22 |
Sep-22 |
Jun-22 |
Mar-22 |
Dec-21 |
Sep-21 |
Jun-21 |
Mar-21 |
Dec-20 |
Sep-20 |
Jun-20 |
Mar-20 |
Dec-19 |
Sep-19 |
Jun-19 |
Mar-19 |
Dec-18 |
Jun-18 |
Mar-18 |
Dec-17 |
| Net income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Depreciation, depletion and amortization |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Stock-based compensation |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.05 |
0.01 |
0.01 |
0.01 |
0.01 |
0.00 |
0.01 |
0.00 |
0.01 |
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Change in inventory |
|
|
|
|
|
|
|
|
|
0.01 |
-0.01 |
0.00 |
|
0.00 |
0.00 |
|
|
0.00 |
0.00 |
0.00 |
-0.01 |
0.00 |
0.00 |
0.01 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
0.00 |
0.00 |
|
| Other working capital changes |
-0.04 |
-0.03 |
-0.04 |
-0.03 |
-0.04 |
-0.05 |
-0.03 |
-0.11 |
-0.07 |
-0.07 |
-0.05 |
-0.05 |
-0.04 |
-0.04 |
-0.04 |
-0.03 |
-0.03 |
-0.02 |
-0.02 |
-0.03 |
-0.02 |
-0.02 |
-0.01 |
-0.02 |
-0.01 |
-0.01 |
0.00 |
-0.01 |
-0.01 |
-0.01 |
-0.02 |
0.00 |
-0.01 |
| Capital expenditures |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Others incl. marketable securities changes |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Dividend payout |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.00 |
0.00 |
0.00 |
| Common stock repurchases |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net Debt Issuance |
0.08 |
0.00 |
0.00 |
0.00 |
0.10 |
0.00 |
0.00 |
0.03 |
0.04 |
0.00 |
0.20 |
0.00 |
0.00 |
0.16 |
0.00 |
0.06 |
0.04 |
0.04 |
0.00 |
0.04 |
0.00 |
0.02 |
0.14 |
0.02 |
0.00 |
0.00 |
0.00 |
0.04 |
0.01 |
0.01 |
0.01 |
0.00 |
0.00 |
|
| Change in cash |
0.04 |
-0.03 |
-0.03 |
-0.03 |
0.06 |
-0.04 |
-0.03 |
-0.03 |
-0.03 |
-0.06 |
0.14 |
-0.04 |
-0.04 |
0.13 |
-0.03 |
0.03 |
0.01 |
0.02 |
-0.01 |
0.02 |
-0.02 |
0.00 |
0.12 |
0.01 |
-0.01 |
-0.01 |
0.00 |
0.02 |
0.00 |
0.00 |
-0.01 |
0.00 |
-0.01 |
Inhibrx Biosciences, Inc. (INBX) - Retained Earnings
Inhibrx Biosciences, Inc. (INBX) - Total Shareholder Equity
Inhibrx Biosciences, Inc. (INBX) - Other Current Liabilities
Inhibrx Biosciences, Inc. (INBX) - Short Long Term Debt Total
Inhibrx Biosciences, Inc. (INBX) - Long Term Debt
Inhibrx Biosciences, Inc. (INBX) - Capital Lease Obligations
Inhibrx Biosciences, Inc. (INBX) - Total Non Current Liabilities
Inhibrx Biosciences, Inc. (INBX) - Short Term Debt
Inhibrx Biosciences, Inc. (INBX) - Current Accounts Payable
Inhibrx Biosciences, Inc. (INBX) - Total Current Liabilities